These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8912368)

  • 21. Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapy.
    Blaickner M; Baum RP
    PET Clin; 2014 Jan; 9(1):99-112. PubMed ID: 25029939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetry in Peptide radionuclide receptor therapy: a review.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From the magic bullet to an effective therapy: the peptide experience.
    Mansi L
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1393-8. PubMed ID: 15351914
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium.
    Chapman JD; Bradley JD; Eary JF; Haubner R; Larson SM; Michalski JM; Okunieff PG; Strauss HW; Ung YC; Welch MJ
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):294-301. PubMed ID: 12527041
    [No Abstract]   [Full Text] [Related]  

  • 25. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-specific dosimetry in radionuclide therapy.
    Lyra M; Lagopati N; Charalambatou P; Vamvakas I
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):258-63. PubMed ID: 21831867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposition: positron imaging with SPECT and dual-head scintillation cameras obviates the need for PET in oncologic imaging.
    Madsen MT; Harkness BA
    Med Phys; 1998 Nov; 25(11):2116-8. PubMed ID: 9829235
    [No Abstract]   [Full Text] [Related]  

  • 28. A generalized 4D image registration scheme for targeted radionuclide therapy dosimetry.
    Papavasileiou P; Divoli A; Hatziioannou K; Flux GD
    Cancer Biother Radiopharm; 2007 Feb; 22(1):160-5. PubMed ID: 17627425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State-of-the-art of external photon beam radiation treatment planning. Photon Treatment Planning Collaborative Working Group.
    Int J Radiat Oncol Biol Phys; 1991 May; 21(1):9-23. PubMed ID: 2032900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclide purity and radiation dosimetry of 124I used in positron tomography of the thyroid.
    Akbari RB; Ott RJ; Trott NG; Sharma HL; Smith AG
    Phys Med Biol; 1986 Jul; 31(7):789-91. PubMed ID: 3749264
    [No Abstract]   [Full Text] [Related]  

  • 31. An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy.
    Leichner PK; Koral KF; Jaszczak RJ; Green AJ; Chen GT; Roeske JC
    Med Phys; 1993; 20(2 Pt 2):569-77. PubMed ID: 8492765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical aspects of scintigraphy-based dosimetry for nuclear medicine therapy.
    Geworski L; Schaefer A; Knoop BO; Pinkert J; Plotkin M; Kirsch CM
    Nuklearmedizin; 2010; 49(3):85-95. PubMed ID: 20505893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Present and future prospects of external radiation cancer treatment].
    Valuckas KP; Aleknavicius E; Grybauskas M
    Medicina (Kaunas); 2004; 40(12):1133-42. PubMed ID: 15630338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan.
    D'Arienzo M; Cicone F; Chiacchiararelli L; Coniglio A; Delaloye AB; Scopinaro F
    Cancer Biother Radiopharm; 2012 Mar; 27(2):124-33. PubMed ID: 22283680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining dosimetry for targeted radionuclide and external beam therapies using the biologically effective dose.
    Bodey RK; Flux GD; Evans PM
    Cancer Biother Radiopharm; 2003 Feb; 18(1):89-97. PubMed ID: 12667312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technical aspects of positron emission tomography/computed tomography fusion planning.
    Brunetti J; Caggiano A; Rosenbluth B; Vialotti C
    Semin Nucl Med; 2008 Mar; 38(2):129-36. PubMed ID: 18243848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of the accuracy of image registration of SPECT images for 3D targeted radionuclide therapy dosimetry.
    Papavasileiou P; Divoli A; Hatziioannou K; Flux GD
    Phys Med Biol; 2007 Dec; 52(24):N539-48. PubMed ID: 18065833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three dosimetry models of lipoma arborescens treated by 90Y synovectomy.
    O'Doherty J; Clauss R; Scuffham J; Khan A; Petitguillaume A; Desbrée A
    Med Phys; 2014 May; 41(5):052501. PubMed ID: 24784398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative SPECT imaging for diagnosis and dosimetry in radionuclide therapy.
    Logan KW
    Int J Rad Appl Instrum B; 1987; 14(3):205-9. PubMed ID: 3499423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MABDOS: a generalized program for internal radionuclide dosimetry.
    Johnson TK
    Comput Methods Programs Biomed; 1988; 27(2):159-67. PubMed ID: 3180752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.